A new approach to Parkinson's disease combining caffeine, methylphenidate, and anticholinergic agents: case histories, pharmacological data, and a conceptual framework from traditional Chinese medicine.
Alisky
J M
JM
D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002110:Caffeine / Q000008:administration & dosage* / Q000494:pharmacology; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008516:Medicine, Chinese Traditional; D008774:Methylphenidate / Q000008:administration & dosage* / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D008774:Methylphenidate; D002110:Caffeine